Oramed Pharmaceuticals Inc. (ORMP)

NASDAQ: ORMP · Real-Time Price · USD

4.620

-0.050 (-1.07%)

At close: Sep 15, 2026, 4:00 PM EDT

4.620

0.00 (0.00%)

After-hours: Sep 15, 2026, 4:15 PM EDT

Oramed Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 15, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	192	113	98	93	471	544
Market Cap Growth	94.51%	16.28%	4.69%	-80.20%	-13.48%	-15.00%
Enterprise Value	120	-21	-46	-9	311	444
Last Close Price	4.67	2.66	2.26	2.15	11.21	13.31

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 15, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	1.13	1.79	-	16.87	-	-
Forward PE	-	14.40	14.40	14.40	14.40	14.40
PS Ratio	-	56.72	-	69.54	174.08	200.54
PB Ratio	0.61	0.57	0.67	0.57	3.11	3.26
P/TBV Ratio	0.61	0.57	0.67	0.57	3.10	3.27

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 15, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	-	-	-	-	115.15	163.83

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 15, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.00	0.00	0.00	0.32	0.01	0.00
Net Debt / Equity Ratio	-0.23	-0.67	-0.97	-0.69	-1.02	-0.90
Net Debt / EBITDA Ratio	4.98	8.92	11.25	7.21	3.82	4.05
Net Debt / FCF Ratio	13.76	14.58	16.79	10.64	5.45	4.48
Asset Turnover	-	0.01	-	0.01	0.02	-
Quick Ratio	4.85	6.62	24.97	3.05	27.10	19.85
Current Ratio	4.98	6.98	25.19	3.06	27.34	20.08
Return on Equity (ROE)	74.24%	37.10%	-12.39%	3.24%	-23.77%	-
Return on Assets (ROA)	-3.42%	-4.88%	-4.25%	-5.16%	-14.95%	-
Return on Invested Capital (ROIC)	-5.23%	-32.68%	-45.44%	-64.63%	-473.17%	-169.08%
Return on Capital Employed (ROCE)	-4.00%	-7.10%	-8.50%	-9.40%	-26.00%	-21.70%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 15, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	90.18%	56.46%	-19.54%	5.93%	-7.77%	-6.44%
FCF Yield	-2.70%	-8.07%	-8.64%	-11.32%	-6.04%	-6.14%
Buyback Yield / Dilution	-2.31%	-3.84%	-0.70%	-4.02%	-5.08%	-30.36%

SEC Filings: 10-K · 10-Q